Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rumin8 develops proprietary tribromomethane-based feed additives that reduce enteric methane emissions from ruminant livestock by up to ~95% while also improving productivity metrics such as weight gain. The company has completed over twenty live animal trials globally with positive results and has begun early commercial rollout following provisional regulatory approvals. Their approach leverages pharmaceutical manufacturing techniques to deliver consistent, scalable solutions targeting climate impact from agriculture.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rumin8.